About This Webinar
Right Treatment, Right Time: Understanding the Wait and Preparing to Act in MDS Management
This webinar, hosted by The MDS Foundation, is designed to help people living with myelodysplastic syndromes (MDS), and those supporting them, understand:
- Why “watchful waiting” or holding off on certain interventions can sometimes be the best choice
- What your care team is monitoring, and how to prepare so you can move quickly and confidently when certain treatments are indicated.
We will connect symptoms, lab trends, and prognostic scoring systems to risk-informed treatment decisions (growth factors, transfusions, medications, clinical trials, and transplant planning) and share checklists and questions you can bring to clinic to make visits more productive.
Webinar Date: April 4
Webinar Time: 12 p.m. - 1:30 p.m. ET
Featured Speakers:
Danielle Hammond
Danielle Hammond, MD is a Canadian-trained hematologist and Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center. She is a clinician-investigator in the Myelodysplastic Syndromes Section and co-leads the Clonal Hematopoiesis and Leukemia Prevention Clinic, which focuses on risk-adapted early intervention strategies for individuals with at-risk clonal hematopoiesis.
Dr. Hammond also serves as Co-Director of the ImmunoHeme CONVERGE Clinic, a first-of-its-kind multidisciplinary program that integrates expertise from leukemia, rheumatology-immunology, dermatology, infectious diseases, and pulmonary medicine. This clinic provides comprehensive evaluation and management for patients with clonally driven hematologic disorders complicated by complex autoimmune or autoinflammatory manifestations, with a particular emphasis on VEXAS syndrome.
About This Webinar
Right Treatment, Right Time: Understanding the Wait and Preparing to Act in MDS Management
This webinar, hosted by The MDS Foundation, is designed to help people living with myelodysplastic syndromes (MDS), and those supporting them, understand:
- Why “watchful waiting” or holding off on certain interventions can sometimes be the best choice
- What your care team is monitoring, and how to prepare so you can move quickly and confidently when certain treatments are indicated.
We will connect symptoms, lab trends, and prognostic scoring systems to risk-informed treatment decisions (growth factors, transfusions, medications, clinical trials, and transplant planning) and share checklists and questions you can bring to clinic to make visits more productive.
Webinar Date: April 4
Webinar Time: 12 p.m. - 1:30 p.m. ET
Featured Speakers:
Danielle Hammond
Danielle Hammond, MD is a Canadian-trained hematologist and Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center. She is a clinician-investigator in the Myelodysplastic Syndromes Section and co-leads the Clonal Hematopoiesis and Leukemia Prevention Clinic, which focuses on risk-adapted early intervention strategies for individuals with at-risk clonal hematopoiesis.
Dr. Hammond also serves as Co-Director of the ImmunoHeme CONVERGE Clinic, a first-of-its-kind multidisciplinary program that integrates expertise from leukemia, rheumatology-immunology, dermatology, infectious diseases, and pulmonary medicine. This clinic provides comprehensive evaluation and management for patients with clonally driven hematologic disorders complicated by complex autoimmune or autoinflammatory manifestations, with a particular emphasis on VEXAS syndrome.